Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bio-Techne Corporation
Asia Deal Watch: Rona Takes On Sanofi’s siRNA Platform
Rona hopes technology acquired from Sanofi will enhance its RNA capabilities in liver and non-liver indications. NeuroFront gets Greater China and Singapore rights to Novaremed’s neuropathic pain drug.
Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis
Argenx partners with Elektrofi and Iontas; China’s Qilu obtains global rights to Peptron’s antibody-drug conjugate and also ends co-development pact with Quantum Genomics.
Kantaro Sees Important Role For New Antibody Test During Next Phase Of Pandemic
The company is planning to produce up to 10 million COVID-SeroKlir SARS-CoV-2 IgG antibody test kits a month through a partnership with Bio-Techne.
Breakthrough Status, Big Investments For Liquid Biopsies
The growth potential of liquid biopsy diagnostics is drawing increasing attention, with several recent breakthrough device designations from the US FDA, big funding rounds, and major acquisitions all in play.
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Urine-based Testing
Drug Discovery Tools
- Large Molecule
- Other Names / Subsidiaries
- Asuragen, Inc.
- Bio-Techne Corp
- Exosome Diagnostics
- Novus Biologicals
- Quad Technologies Inc.
- R&D Systems
- RNA Medical
- Scientific Ventures
- Tocris Holdings Limited
- Trevigen Inc.
- Zephyrus Biosciences Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.